NRx Pharmaceuticals Inc (NASDAQ:NRXPW) — Market Cap & Net Worth
Market Cap & Net Worth: NRx Pharmaceuticals Inc (NRXPW)
NRx Pharmaceuticals Inc (NASDAQ:NRXPW) has a market capitalization of $140.04 ($140.04) as of September 18, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #32009 globally and #6429 in its home market, demonstrating a 91.89% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying NRx Pharmaceuticals Inc's stock price $0.01 by its total outstanding shares 9862 (9.86K). Also see NRXPW total assets for a full breakdown of the balance sheet.
NRx Pharmaceuticals Inc Market Cap History: 2017 to 2026
NRx Pharmaceuticals Inc's market capitalization history from 2017 to 2026. Data shows change from $3.94K to $140.04 (-31.48% CAGR). Also see NRXPW cash flow conversion for how efficiently the company converts equity into cash flow.
NRx Pharmaceuticals Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how NRx Pharmaceuticals Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check NRx Pharmaceuticals Inc stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
0.00x
NRx Pharmaceuticals Inc's market cap is 0.00 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2018 | $3.79K | $1.09 Million | $66.10K | 0.00x | 0.06x |
| 2019 | $1.71K | $1.21 Million | $408.43K | 0.00x | 0.00x |
| 2025 | $698.23 | $1.23 Million | -$28.62 Million | 0.00x | N/A |
Competitor Companies of NRXPW by Market Capitalization
Companies near NRx Pharmaceuticals Inc in the global market cap rankings as of September 18, 2026. Review NRx Pharmaceuticals Inc (NRXPW) tangible net worth to assess the quality of the company's equity after excluding intangible assets.
Key companies related to NRx Pharmaceuticals Inc by market ranking:
- Pyxis Tankers Inc (NASDAQ:PXSAW): Ranked #32000 globally with a market cap of $190.61 USD.
- Shineco Inc (NASDAQ:SISI): Ranked #32001 globally with a market cap of $180.12 USD.
- Ethernity Networks Ltd (LSE:ENET): Ranked #32010 globally with a market cap of $133.84 USD ( GBX1.10 Million GBX).
- CuriosityStream Inc (NASDAQ:CURIW): Ranked #32011 globally with a market cap of $123.08 USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #32000 | Pyxis Tankers Inc | NASDAQ:PXSAW | $190.61 | $0.02 |
| #32001 | Shineco Inc | NASDAQ:SISI | $180.12 | $0.00 |
| #32010 | Ethernity Networks Ltd | LSE:ENET | $133.84 | GBX0.00 |
| #32011 | CuriosityStream Inc | NASDAQ:CURIW | $123.08 | $0.01 |
NRx Pharmaceuticals Inc Historical Marketcap From 2017 to 2026
Between 2017 and today, NRx Pharmaceuticals Inc's market cap moved from $3.94K to $ 140.04, with a yearly change of -31.48%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $140.04 | -79.94% |
| 2025 | $698.23 | -44.69% |
| 2024 | $1.26K | -1.31% |
| 2023 | $1.28K | -48.14% |
| 2022 | $2.47K | -86.48% |
| 2021 | $18.24K | -60.64% |
| 2020 | $46.35K | +2608.93% |
| 2019 | $1.71K | -54.85% |
| 2018 | $3.79K | -3.92% |
| 2017 | $3.94K | -- |
End of Day Market Cap According to Different Sources
On Sep 17th, 2026 the market cap of NRx Pharmaceuticals Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $140.04 USD |
| MoneyControl | $140.04 USD |
| MarketWatch | $140.04 USD |
| marketcap.company | $140.04 USD |
| Reuters | $140.04 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About NRx Pharmaceuticals Inc
NRx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapeutics for the treatment of central nervous system disorders comprising suicidal depression, post-traumatic stress disorder (PTSD), and schizophrenia in the United States. It operates through NRx and Dura segments. The company develops NRX-101, an oral fixed-dose combination of D-cycloserine (DCS) and lurasidone… Read more